Search Results - Xiaoqin Dai
- Showing 1 - 2 results of 2
-
1
Immune-related adverse events in small-cell lung cancer patients treated with immune checkpoint inhibitors: a comprehensive analysis from the FDA adverse event reporting system by Yifeng Bai, Yifeng Bai, Xiaomei Wang, Xiaomei Wang, Xiaoqin Dai, Xiaoqin Dai, Qinghua Ma, Qinghua Ma, Honglin Hu, Honglin Hu
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Discovery and development of Factor Xa inhibitors (2015-2022) by Wei Zheng, Wei Zheng, Xiaoqin Dai, Binyao Xu, Wei Tian, Jianyou Shi
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book